Therapeutics

Innovative Treatments Chronic Disease Management Psychedelic Therapy Oncology Precision Medicine Treatment Options Infant Health Skin Diseases Drug Development Infectious Diseases Oncology Drugs Treatment Strategies Psychedelic Medicine Preclinical Research Metabolic Disorders Antibody Therapy Drug Targets Treatment Development Antimicrobial Strategies Neurology Non-Pharmaceutical Treatments Cell Therapy Antiviral Treatments Genetic Medicines Cancer Treatment Epilepsy Treatment

HRSA Says 340B Covered Entities Bought $100 Billion in Outpatient Drugs in 2025

Specialty and oncology therapies shifting to outpatient care are driving the jump and prompting legal fights over drugmakers’ demands for detailed claims data.

Duke Scientists Grow Retinal Blood-Vessel Cells From Human iPSCs

Study in Mice Maps Brain–Heart Loop That Worsens Recovery After Heart Attack

UMC Utrecht Reports First FcγRI-Blocking Antibodies With Preclinical Efficacy

Duke-NUS Team Publishes Single-Cell Fetal Brain Atlas to Benchmark Parkinson’s Models

UC Davis Mouse Study Finds Psilocybin Worsened Postpartum Behaviors and Produced Lasting Offspring Effects

Mix-and-Go Cubosome Method Achieves Over 98% mRNA Encapsulation and Advances Toward Clinical Scale-Up

Llama-Derived Nanobody Therapy Poised for Human Trials in Schizophrenia